• When September, 2026
  • Where Barcelona
  • Search

Step Into the Spotlight at the Innovation Exchange

Having launched at Advanced Therapies Europe 2025, the Innovation Exchange debuted as a high-impact pitching competition connecting pre-Series B biotech innovators with the industry’s leading investors, VCs, and strategic partners. A platform to get noticed, get feedback, and get connected. If you're building the future of cell and gene therapy in 2026, this is the moment to stand out.

Apply to take part in 2026

Sponsored by
Medicpres

Congratulations to our 2025 Innovation Exchange winner

          kbio

innovation exchange winner


Thank you to our 2025 finalists...

Developing a novel gene therapy technology that cuts complexity and cost and makes AAV manufacturing viable at scale - to reach more patients, more quickly, and in more disease areas.

Combining CAR T and oncolytic virus technologies with an immune-enhancing platform to outsmart cancer.
Developing child-first cancer gene therapies to deliver safe, effective immunotherapies for paediatric patients.
Creating truly personalised cancer immunotherapies using proprietary tumour-specific mutations and AI-driven T-cell selection.
Powering safer cell therapies with RNA-based purification that removes unwanted cells from stem cell manufacturing.
Delivering curative in vivo gene therapies with engineered viral vectors designed for precise, durable genetic correction.

What Is the Innovation Exchange?

The Innovation Exchange is a curated live pitching session taking place on 4 September in Barcelona — part of the main agenda at Advanced Therapies Europe. Attending startups will pitch in front of the entire conference audience and a selection panel made up of top-tier investors and pharma deal-makers.

Finalists will receive real-time feedback and the opportunity to gain funding, partnerships, and visibility across the global advanced therapies community.

ENTRIES ARE CLOSED!

Who Can Apply?

The Innovation Exchange is open to pre-Series B startups across the cell and gene therapy ecosystem, including:

  • Novel therapeutics
  • Enabling & manufacturing technologies
  • Digital health tools
  • Automation & analytics platforms
  • Supply chain or regulatory innovation

Want a preview of the ATE community?

See who was in the room this year and the organisations leading the way in advanced therapies.

Download the 2025 Attendee List